This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Bovie Medical Corporation Reports 9.4 Percent Increase In First Quarter Revenues; Reports Positive Results In J-Plasma™ Surgeries

Bovie Medical Corporation (the “Company”) (NYSE MKT: BVX), a manufacturer and marketer of electrosurgical products, today announced its financial results for the first quarter ended March 31, 2012.

For the first quarter of fiscal 2012, ended March 31, 2012 revenues increased 9.4% to $6.73 million when compared to $6.15 in the same period last year. Net income for the current year first quarter was $321,000 or $.01 per diluted share versus $674,000 or $.03 per diluted in the first three months of fiscal 2011.

In addition to the condensed statement of operations in accordance with GAAP, we have included a pro-forma of income (loss) from operations, which excludes the one-time legal settlement gain from the first quarter of 2011. This resulted in our pro-forma income (loss) from operations improving by approximately $561,000 over the prior period.

During the first three months of 2012, Bovie experienced increases in sales across all product lines and this trend has continued into the second quarter.

J-PLASMA™

Jeff Rencher, Vice President of Sales and Marketing of Surgical Products, spearheading the launch of J-Plasma™, commented, “As Bovie prepares the near term delivery of J-Plasma™ units to university/hospital beta sites, we are both assured and encouraged by its performance as reported by Matt G. Oakes, DVM, Diplomat, American College of Veterinary Surgeons, Tampa Bay Veterinary Specialists.”

Dr. Oakes stated, “Tampa Bay Veterinary Surgery has been excited to try out the new technology behind the J-Plasma™ unit brought to us by Bovie. We have found the cutting mode with the extended blade to work extremely well for skin incisions in dogs. The skin cuts with no resistance, no visible incisional edge char, and minimal smoke or odor. Recheck of our initial cases at 2 weeks showed excellent healing without crusting of the incision line that is typical of those incised with traditional electrocautery. The J-Plasma™ beam is useful for coagulation of small vessels and we are continuing to try varied settings to optimize this function. We are looking forward to trying J-Plasma™ for other applications such as oral and soft palate surgery, liver hemostasis, and tumor bed treatment.”

Stock quotes in this article: BVX 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,262.56 +89.32 0.55%
S&P 500 1,842.98 +12.37 0.68%
NASDAQ 4,034.1610 +11.4670 0.29%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs